454 related articles for article (PubMed ID: 33586127)
1. Serum KL-6, CA19-9, CA125 and CEA are Diagnostic Biomarkers for Rheumatoid Arthritis-Associated Interstitial Lung Disease in the Chinese Population.
Zheng M; Lou A; Zhang H; Zhu S; Yang M; Lai W
Rheumatol Ther; 2021 Mar; 8(1):517-527. PubMed ID: 33586127
[TBL] [Abstract][Full Text] [Related]
2. Serum Krebs von den Lungen-6 and lung ultrasound B lines as potential diagnostic and prognostic factors for rheumatoid arthritis-associated interstitial lung disease.
Fotoh DS; Helal A; Rizk MS; Esaily HA
Clin Rheumatol; 2021 Jul; 40(7):2689-2697. PubMed ID: 33474659
[TBL] [Abstract][Full Text] [Related]
3. Tumour markers in rheumatoid arthritis-associated interstitial lung disease.
Wang T; Zheng XJ; Ji YL; Liang ZA; Liang BM
Clin Exp Rheumatol; 2016; 34(4):587-91. PubMed ID: 27213221
[TBL] [Abstract][Full Text] [Related]
4. The value of serum Krebs von den lungen-6 as a diagnostic marker in connective tissue disease associated with interstitial lung disease.
Ma H; Lu J; Song Y; Wang H; Yin S
BMC Pulm Med; 2020 Jan; 20(1):6. PubMed ID: 31915006
[TBL] [Abstract][Full Text] [Related]
5. Identification of biomarkers by machine learning classifiers to assist diagnose rheumatoid arthritis-associated interstitial lung disease.
Qin Y; Wang Y; Meng F; Feng M; Zhao X; Gao C; Luo J
Arthritis Res Ther; 2022 May; 24(1):115. PubMed ID: 35590341
[TBL] [Abstract][Full Text] [Related]
6. Improving risk-stratification of rheumatoid arthritis patients for interstitial lung disease.
Avouac J; Cauvet A; Steelandt A; Shirai Y; Elhai M; Kuwana M; Distler O; Allanore Y
PLoS One; 2020; 15(5):e0232978. PubMed ID: 32384128
[TBL] [Abstract][Full Text] [Related]
7. Multidimensional biomarker approach integrating tumor markers, inflammatory indicators, and disease activity indicators may improve prediction of rheumatoid arthritis-associated interstitial lung disease.
Wan J; Yu Z; Cao X; Zhao X; Zhou W; Zheng Y
Clin Rheumatol; 2024 Jun; 43(6):1855-1863. PubMed ID: 38704780
[TBL] [Abstract][Full Text] [Related]
8. Increased lung cancer risk in patients with interstitial lung disease and elevated CEA and CA125 serum tumour markers.
Dai H; Liu J; Liang L; Ban C; Jiang J; Liu Y; Ye Q; Wang C
Respirology; 2014 Jul; 19(5):707-13. PubMed ID: 24903079
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the Clinical Value of KL-6 and Tumor Markers in Primary Sjögren's Syndrome Complicated with Interstitial Lung Disease.
Wei F; Zhang X; Yang S; Geng J; Xie B; Ren Y; Dai H
J Clin Med; 2023 Jul; 12(15):. PubMed ID: 37568332
[TBL] [Abstract][Full Text] [Related]
10. The role of lung ultrasound B-lines and serum KL-6 in the screening and follow-up of rheumatoid arthritis patients for an identification of interstitial lung disease: review of the literature, proposal for a preliminary algorithm, and clinical application to cases.
Wang Y; Chen S; Zheng S; Lin J; Hu S; Zhuang J; Lin Q; Xie X; Zheng K; Zhang W; Du G; Zhang G; Hoffmann-Vold AM; Matucci-Cerinic M; Furst DE
Arthritis Res Ther; 2021 Aug; 23(1):212. PubMed ID: 34391465
[TBL] [Abstract][Full Text] [Related]
11. Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease.
Benyamine A; Heim X; Resseguier N; Bertin D; Gomez C; Ebbo M; Harlé JR; Kaplanski G; Rossi P; Bardin N; Granel B
Rheumatol Int; 2018 May; 38(5):813-819. PubMed ID: 29455320
[TBL] [Abstract][Full Text] [Related]
12. Identification of serum interleukin-13 and interleukin-13 receptor subunit expressions: Rheumatoid arthritis-associated interstitial lung disease.
Hussein MS; El-Barbary AM; Nada DW; Gaber RA; Elkolaly RM; Aboelhawa MA
Int J Rheum Dis; 2021 Apr; 24(4):591-598. PubMed ID: 33638296
[TBL] [Abstract][Full Text] [Related]
13. Serum KL-6 levels reflect the severity of interstitial lung disease associated with connective tissue disease.
Lee JS; Lee EY; Ha YJ; Kang EH; Lee YJ; Song YW
Arthritis Res Ther; 2019 Feb; 21(1):58. PubMed ID: 30764869
[TBL] [Abstract][Full Text] [Related]
14. Association of serum KL-6 levels with interstitial lung disease in patients with connective tissue disease: a cross-sectional study.
Oguz EO; Kucuksahin O; Turgay M; Yildizgoren MT; Ates A; Demir N; Kumbasar OO; Kinikli G; Duzgun N
Clin Rheumatol; 2016 Mar; 35(3):663-6. PubMed ID: 26758437
[TBL] [Abstract][Full Text] [Related]
15. Krebs von den Lungen-6 associated with chest high-resolution CT score in evaluation severity of patients with interstitial lung disease.
Qin H; Xu XP; Zou J; Zhao XJ; Wu HW; Zha QF; Chen S; Kang Y; Jiang HD
Pulmonology; 2019; 25(3):143-148. PubMed ID: 30007895
[TBL] [Abstract][Full Text] [Related]
16. [The diagnostic value of serum KL-6 in connective tissue disease associated interstitial lung disease].
Wu X; Wu LJ; Luo CN; Shi YM; Zou JM; Meng XY
Zhonghua Yi Xue Za Zhi; 2019 Oct; 99(40):3172-3175. PubMed ID: 31694110
[No Abstract] [Full Text] [Related]
17. Diagnostic Value of Krebs von den Lungen (KL-6) for Interstitial Lung Disease: A European Prospective Cohort.
Millan-Billi P; Castellví I; Martinez-Martinez L; Mariscal A; Barril S; D'Alessandro M; Franquet T; Castillo D
Arch Bronconeumol; 2024 Jun; 60(6):350-355. PubMed ID: 38644152
[TBL] [Abstract][Full Text] [Related]
18. Serum KL-6 level as a biomarker of interstitial lung disease in childhood connective tissue diseases: a pilot study.
Kilinc AA; Arslan A; Yildiz M; Kucur M; Adrovic A; Barut K; Sahin S; Cokugras H; Kasapcopur O
Rheumatol Int; 2020 Oct; 40(10):1701-1706. PubMed ID: 31784789
[TBL] [Abstract][Full Text] [Related]
19. Lung ultrasound B-lines and serum KL-6 correlate with the severity of idiopathic inflammatory myositis-associated interstitial lung disease.
Wang Y; Chen S; Lin J; Xie X; Hu S; Lin Q; Zheng K; Du G; Huang X; Zhang G; Gargani L; Matucci-Cerinic M; Furst DE
Rheumatology (Oxford); 2020 Aug; 59(8):2024-2029. PubMed ID: 31794028
[TBL] [Abstract][Full Text] [Related]
20. Comparative diagnostic efficacy of serum Krebs von den Lungen-6 and surfactant D for connective tissue disease-associated interstitial lung diseases: A meta-analysis.
Zhong D; Wu C; Bai J; Hu C; Xu D; Wang Q; Zeng X
Medicine (Baltimore); 2020 Apr; 99(16):e19695. PubMed ID: 32311947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
